Doctors who helped paralysed man walk seek new patients

Image
AFP Wroclaw (Poland)
Last Updated : Oct 22 2014 | 10:35 PM IST
The paralysed Polish man who regained his ability to walk after receiving revolutionary treatment said today he was a "lucky devil", as his doctors announced they were looking for new candidates for the procedure.
Darek Fidyka, 40, was paralysed from the chest down by a knife attack in 2010 but can now walk using a frame after nerve cells were transplanted into his severed spinal column two years ago.
"I hope to recover further," said Fidyka alongside his doctors at a press conference in the southwestern city of Wroclaw, a day after the research behind the breakthrough treatment was published in the journal Cell Transplantation.
"The attack turned my life upside down. Since the surgical operation, it's been steps in the opposite direction," the former fireman told reporters.
"I'm already able to get myself into bed, to dress and undress without help, to drive," he said, tears welling up in his eyes.
"I'm still having a hard time processing it all. I'm a lucky devil, relatively speaking."
Wlodzimierz Jarmundowicz, who heads neurosurgery at the Polish clinic where the operation was carried out, however cautioned against raising "the hopes of every person with a damaged spine".
The treatment can only be applied to "injuries caused by a sharp instrument, like a machete," he said.
Pawel Tabakow, who led the team of surgeons in the medical procedure, said the injury "is very rare".
They are now looking for two more patients suffering from similar injuries from across the world.
The criteria will be posted, in Polish, on the website of the Akron Neuro-Rehabilitation Centre in Wroclaw where Fidyka was recovering.
An English version will go up on the website of the University College London's Institute of Neurology, whose British research team collaborated on the project.
The two institutions had worked "in synergy" on the project for years, but it was chance that led to the revolutionary treatment, Tabakow said.
He said that doctors generally take the cells that are supposed to promote nerve regeneration straight from the patient's nose. But that was not possible in Fidyka's case because of sinus inflammation.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 22 2014 | 10:35 PM IST

Next Story